Company profile
PetDx company profile
PetDx® – The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients.
Business identity
- Website
- https://petdx.com
- Contact email
- [email protected]
- Phone number
- 833-464-7297
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $1M-$10M
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- San Diego, California, United States
- Postal code
- 92037
- Country code
- US
- Continent
- North America